IS8422A - Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra - Google Patents

Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra

Info

Publication number: IS8422A
Authority: IS; Iceland
Prior art keywords: preparation; preparations containing; benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2003-09-26

Application number

IS8422A

Other languages

English (en)

Inventor

Liu Ziping

Pagé Daniel

Walpole Christopher

Yang Hua

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-26

Filing date

2006-04-21

Publication date

2006-04-21

2006-04-21 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-04-21 Publication of IS8422A publication Critical patent/IS8422A/is

Links

238000002360 preparation method Methods 0.000 title 2
229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IS8422A 2003-09-26 2006-04-21 Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra IS8422A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0302573A SE0302573D0 (sv)	2003-09-26	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PCT/GB2004/004124 WO2005030732A1 (en)	2003-09-26	2004-09-24	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Publications (1)

Publication Number	Publication Date
IS8422A true IS8422A (is)	2006-04-21

Family

ID=29246982

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8422A IS8422A (is)	2003-09-26	2006-04-21	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra

Country Status (33)

Country	Link
US (1)	US8633235B2 (is)
EP (1)	EP1670769B1 (is)
JP (1)	JP4896721B2 (is)
KR (1)	KR101170184B1 (is)
CN (2)	CN1886379A (is)
AR (1)	AR045819A1 (is)
AT (1)	ATE430135T1 (is)
AU (1)	AU2004276062B2 (is)
BR (1)	BRPI0414780B8 (is)
CA (1)	CA2539738C (is)
CO (1)	CO5680443A2 (is)
CY (1)	CY1110332T1 (is)
DE (1)	DE602004020907D1 (is)
DK (1)	DK1670769T3 (is)
ES (1)	ES2324669T3 (is)
HR (1)	HRP20090388T1 (is)
IL (1)	IL174215A0 (is)
IS (1)	IS8422A (is)
MX (1)	MXPA06003197A (is)
MY (1)	MY140630A (is)
NO (1)	NO20061839L (is)
NZ (1)	NZ545736A (is)
PL (1)	PL1670769T3 (is)
PT (1)	PT1670769E (is)
RU (1)	RU2346938C2 (is)
SA (1)	SA04250310B1 (is)
SE (1)	SE0302573D0 (is)
SI (1)	SI1670769T1 (is)
TW (1)	TW200521117A (is)
UA (1)	UA86776C2 (is)
UY (1)	UY28536A1 (is)
WO (1)	WO2005030732A1 (is)
ZA (3)	ZA200602446B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003257145B2 (en)	2002-08-02	2008-11-13	Merck Sharp & Dohme Corp.	Substituted furo (2,3-b) pyridine derivatives
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1797077B1 (en) *	2004-09-24	2012-02-15	AstraZeneca AB	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
ES2380709T3 (es)	2004-09-24	2012-05-17	Astrazeneca Ab	Derivados de bencimidazol, composiciones que los contienen, su preparación y usos
WO2006033630A1 (en) *	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparation thereof and uses thereof iii
CN101031563A (zh) *	2004-09-24	2007-09-05	阿斯利康(瑞典)有限公司	苯并咪唑衍生物、含有它们的组合物、其制备方法和用途
ATE417830T1 (de)	2004-11-02	2009-01-15	Pfizer	Sulfonylbenzimidazolderivate
CN101233098A (zh) *	2005-07-29	2008-07-30	阿斯利康(瑞典)有限公司	成对((二氟环烷基)甲基)胺的制备方法
TW200745049A (en) *	2006-03-23	2007-12-16	Astrazeneca Ab	New crystalline forms
TW200808769A (en)	2006-04-18	2008-02-16	Astrazeneca Ab	Therapeutic compounds
US20080139846A1 (en) *	2006-09-01	2008-06-12	Astrazeneca Ab	New Process 298
EP2070927A4 (en) *	2006-09-13	2010-10-13	Kyowa Hakko Kirin Co Ltd	CONDENSED HETEROCYCLIC DERIVATIVE
US20110086853A1 (en) *	2009-10-08	2011-04-14	William Brown	Therapeutic Compounds
RU2414899C1 (ru) *	2009-12-29	2011-03-27	Аверин Константин Михайлович	Средства для лечения рассеянного склероза
RU2454234C1 (ru) *	2011-03-16	2012-06-27	Константин Михайлович Аверин	Соли 1,3-диэтилбензимидазолия - иммуностимулирующие средства и фармацевтические композиции на их основе
MX376595B (es) *	2012-06-13	2025-03-07	Cytec Tech Corp	Composiciones estabilizadoras que contienen compuestos de cromano sustituidos y metodos de uso.
LT2864291T (lt)	2012-06-26	2017-01-10	Bayer Pharma Aktiengesellschaft	N-[4-(chinolin-4-iloksi)cikloheksil(metil)](hetero)arilkarboksamidai kaip androgeno receptoriaus antagonistai, jų gamyba ir panaudojimas kaip medicininių produktų
CA3093189A1 (en)	2018-03-07	2019-09-12	Bayer Aktiengesellschaft	Identification and use of erk5 inhibitors
WO2020234103A1 (en)	2019-05-21	2020-11-26	Bayer Aktiengesellschaft	Identification and use of kras inhibitors
CN112010789A (zh) *	2019-05-31	2020-12-01	中国科学院上海药物研究所	乙烯基磺酰胺或乙烯基酰胺类化合物及其制备方法和用途
GB202019335D0 (en) *	2020-12-08	2021-01-20	Artelo Biosciences Ltd	Pharmaceutical compositions
WO2023166450A1 (ko) *	2022-03-04	2023-09-07	삼진제약주식회사	신규한 헤테로 고리 화합물 및 이를 포함하는 약학적 조성물

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1604908A (en)	1965-06-24	1971-05-15		Substd benzimidazoles - with anthelmintic,fungicidal activity and some with antiviral and antibacterial activity
FR5354M (is)	1965-09-10	1967-09-11
US5387600A (en)	1992-07-30	1995-02-07	Fuji Photo Film Co., Ltd.	Treating arteriosclerosis using benzimidazole compositions
DE4237557A1 (de)	1992-11-06	1994-05-11	Bayer Ag	Substituierte Benzimidazole
DE4237597A1 (de)	1992-11-06	1994-05-11	Bayer Ag	Substituierte Benzimidazole
DE4237617A1 (de)	1992-11-06	1994-05-11	Bayer Ag	Verwendung von substituierten Benzimidazolen
HUP9900625A3 (en)	1995-12-28	2003-04-28	Fujisawa Pharmaceutical Co	Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
TW453999B (en) *	1997-06-27	2001-09-11	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
US6348032B1 (en)	1998-11-23	2002-02-19	Cell Pathways, Inc.	Method of inhibiting neoplastic cells with benzimidazole derivatives
AU6762400A (en)	1999-08-12	2001-03-13	Cor Therapeutics, Inc.	Inhibitors of factor xa
NZ517828A (en)	1999-09-17	2003-10-31	Millennium Pharm Inc	Inhibitors having activity against mammalian factor Xa
US6632815B2 (en)	1999-09-17	2003-10-14	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
US6720317B1 (en)	1999-09-17	2004-04-13	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
US6844367B1 (en)	1999-09-17	2005-01-18	Millennium Pharmaceuticals, Inc.	Benzamides and related inhibitors of factor Xa
US7115645B2 (en)	2000-01-14	2006-10-03	Schering Aktiengesellschaft	1,2 diarylbenzimidazoles and their pharmaceutical use
BR0107628A (pt) *	2000-01-14	2002-10-08	Schering Ag	l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
US7329679B2 (en) *	2000-01-27	2008-02-12	Schering Aktiengesellschaft	1,2 Diarylbenzimidazoles and their pharmaceutical use
AU2001250783A1 (en)	2000-02-29	2001-09-12	Cor Therapeutics, Inc.	Benzamides and related inhibitors of factor xa
AU2001273040A1 (en)	2000-06-27	2002-01-08	Du Pont Pharmaceuticals Company	Factor xa inhibitors
AU2002221239A1 (en)	2000-12-07	2002-06-18	Astrazeneca Ab	Therapeutic benzimidazole compounds
SE0101387D0 (sv) *	2001-04-20	2001-04-20	Astrazeneca Ab	Novel compounds
US7199147B2 (en)	2001-06-12	2007-04-03	Dainippon Sumitomo Pharma Co., Ltd.	Rho kinase inhibitors
TW200505902A (en)	2003-03-20	2005-02-16	Schering Corp	Cannabinoid receptor ligands
SE0301701D0 (sv)	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301699D0 (sv) *	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005007625A2 (en)	2003-07-14	2005-01-27	The University Of Tennessee Research Foundation	Heterocyclic amides with anti-tuberculosis activity
WO2005021547A2 (en)	2003-08-28	2005-03-10	Pharmaxis Pty Ltd.	Heterocyclic cannabinoid cb2 receptor antagonists
SE0302571D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1758884A2 (en)	2004-05-20	2007-03-07	Elan Pharmaceuticals, Inc.	N-cyclic sulfonamido inhibitors of gamma secretase
US20060135773A1 (en)	2004-06-17	2006-06-22	Semple Joseph E	Trisubstituted nitrogen modulators of tyrosine phosphatases
EP1773768B8 (en)	2004-07-30	2018-12-26	Exelixis, Inc.	Pyrrole derivatives as pharmaceutical agents
US20060052421A1 (en)	2004-09-09	2006-03-09	Eastman Kodak Company	Conjugation agent
EP1797077B1 (en)	2004-09-24	2012-02-15	AstraZeneca AB	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
WO2006033632A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Benzimidazole derivatives and their use as cannabinoid receptor ligands I
JP2008514595A (ja)	2004-09-24	2008-05-08	アストラゼネカ・アクチエボラーグ	化合物、それを含有する組成物、その製造及びその使用ｉｉ
WO2006033629A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Benzimidazole derivatives and their use as cannabinoid receptor ligands
EP1797076A1 (en)	2004-09-24	2007-06-20	AstraZeneca AB	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2006033627A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparation thereof and uses thereof iiii
WO2006033630A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparation thereof and uses thereof iii
ES2380709T3 (es) *	2004-09-24	2012-05-17	Astrazeneca Ab	Derivados de bencimidazol, composiciones que los contienen, su preparación y usos
ATE417830T1 (de)	2004-11-02	2009-01-15	Pfizer	Sulfonylbenzimidazolderivate
WO2006078941A2 (en)	2005-01-20	2006-07-27	Sirtris Pharmaceuticals, Inc.	Novel sirtuin activating compounds and methods of use thereof
TW200745049A (en)	2006-03-23	2007-12-16	Astrazeneca Ab	New crystalline forms
TW200808769A (en)	2006-04-18	2008-02-16	Astrazeneca Ab	Therapeutic compounds
TW200808772A (en)	2006-06-13	2008-02-16	Astrazeneca Ab	Therapeutic compounds

2003
- 2003-09-26 SE SE0302573A patent/SE0302573D0/xx unknown
2004
- 2004-09-24 UY UY28536A patent/UY28536A1/es unknown
- 2004-09-24 CN CNA2004800350086A patent/CN1886379A/zh active Pending
- 2004-09-24 MX MXPA06003197A patent/MXPA06003197A/es active IP Right Grant
- 2004-09-24 RU RU2006113371/04A patent/RU2346938C2/ru active
- 2004-09-24 DK DK04768667T patent/DK1670769T3/da active
- 2004-09-24 KR KR1020067005825A patent/KR101170184B1/ko not_active Expired - Lifetime
- 2004-09-24 DE DE602004020907T patent/DE602004020907D1/de not_active Expired - Lifetime
- 2004-09-24 AR ARP040103467A patent/AR045819A1/es not_active Application Discontinuation
- 2004-09-24 ES ES04768667T patent/ES2324669T3/es not_active Expired - Lifetime
- 2004-09-24 MY MYPI20043910A patent/MY140630A/en unknown
- 2004-09-24 BR BRPI0414780A patent/BRPI0414780B8/pt not_active IP Right Cessation
- 2004-09-24 TW TW093129150A patent/TW200521117A/zh unknown
- 2004-09-24 CA CA2539738A patent/CA2539738C/en not_active Expired - Lifetime
- 2004-09-24 PT PT04768667T patent/PT1670769E/pt unknown
- 2004-09-24 EP EP04768667A patent/EP1670769B1/en not_active Expired - Lifetime
- 2004-09-24 HR HR20090388T patent/HRP20090388T1/xx unknown
- 2004-09-24 NZ NZ545736A patent/NZ545736A/en unknown
- 2004-09-24 AT AT04768667T patent/ATE430135T1/de active
- 2004-09-24 UA UAA200602693A patent/UA86776C2/ru unknown
- 2004-09-24 SI SI200431166T patent/SI1670769T1/sl unknown
- 2004-09-24 US US10/573,054 patent/US8633235B2/en active Active
- 2004-09-24 AU AU2004276062A patent/AU2004276062B2/en not_active Expired
- 2004-09-24 CN CN2010105277900A patent/CN102010373A/zh active Pending
- 2004-09-24 PL PL04768667T patent/PL1670769T3/pl unknown
- 2004-09-24 WO PCT/GB2004/004124 patent/WO2005030732A1/en not_active Ceased
- 2004-09-24 JP JP2006527490A patent/JP4896721B2/ja not_active Expired - Lifetime
- 2004-09-26 SA SA04250310A patent/SA04250310B1/ar unknown
2006
- 2006-03-09 IL IL174215A patent/IL174215A0/en unknown
- 2006-03-22 CO CO06028452A patent/CO5680443A2/es not_active Application Discontinuation
- 2006-03-24 ZA ZA200602446A patent/ZA200602446B/en unknown
- 2006-04-21 IS IS8422A patent/IS8422A/is unknown
- 2006-04-26 NO NO20061839A patent/NO20061839L/no not_active Application Discontinuation
2007
- 2007-03-13 ZA ZA200702131A patent/ZA200702131B/xx unknown
- 2007-03-16 ZA ZA200702226A patent/ZA200702226B/xx unknown
2009
- 2009-07-08 CY CY20091100725T patent/CY1110332T1/el unknown

Also Published As

Publication number	Publication date
NZ545736A (en)	2009-11-27
IL174215A0 (en)	2006-08-01
RU2006113371A (ru)	2007-11-10
DE602004020907D1 (de)	2009-06-10
EP1670769A1 (en)	2006-06-21
SI1670769T1 (sl)	2009-10-31
AR045819A1 (es)	2005-11-16
TW200521117A (en)	2005-07-01
BRPI0414780B8 (pt)	2021-05-25
ES2324669T3 (es)	2009-08-12
HRP20090388T1 (hr)	2009-08-31
AU2004276062B2 (en)	2008-05-22
NO20061839L (no)	2006-06-26
CN102010373A (zh)	2011-04-13
CO5680443A2 (es)	2006-09-29
CA2539738A1 (en)	2005-04-07
UA86776C2 (ru)	2009-05-25
CN1886379A (zh)	2006-12-27
HK1089436A1 (en)	2006-12-01
SA04250310B1 (ar)	2009-01-19
JP4896721B2 (ja)	2012-03-14
KR20070001052A (ko)	2007-01-03
CA2539738C (en)	2011-11-22
UY28536A1 (es)	2005-04-29
ATE430135T1 (de)	2009-05-15
WO2005030732A1 (en)	2005-04-07
BRPI0414780A (pt)	2006-11-21
DK1670769T3 (da)	2009-08-10
PL1670769T3 (pl)	2009-09-30
SE0302573D0 (sv)	2003-09-26
RU2346938C2 (ru)	2009-02-20
EP1670769B1 (en)	2009-04-29
PT1670769E (pt)	2009-07-09
CY1110332T1 (el)	2015-01-14
ZA200702226B (en)	2009-01-28
MXPA06003197A (es)	2006-06-23
US8633235B2 (en)	2014-01-21
KR101170184B1 (ko)	2012-07-31
JP2007506721A (ja)	2007-03-22
US20080207612A1 (en)	2008-08-28
BRPI0414780B1 (pt)	2018-10-23
ZA200602446B (en)	2007-09-26
ZA200702131B (en)	2008-08-27
MY140630A (en)	2010-01-15
AU2004276062A1 (en)	2005-04-07

Publication	Publication Date	Title
IS8422A (is)	2006-04-21	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
DK1673349T3 (da)	2010-10-25	Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
IS6661A (is)	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
IS8219A (is)	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
IS7079A (is)	2003-12-15	Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
IL177533A (en)	2010-12-30	Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them
IS2458B (is)	2008-11-15	Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
IS7491A (is)	2004-10-06	Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
DK1095025T3 (da)	2003-04-07	Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IS8220A (is)	2006-01-04	Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun
DK1334106T3 (da)	2006-09-18	Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
NO20053809D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
SI1673349T1 (sl)	2010-10-29	Derivati benzimidazola: priprava in farmacevtske uporabe
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
DK1773829T3 (da)	2009-04-20	Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
NO20053805D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
DK1791872T3 (da)	2009-05-04	Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
NO20055142D0 (no)	2005-11-02	Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
DK1781631T3 (da)	2012-05-14	Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf